Correlation Between Cell Impact and VIMAB Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cell Impact and VIMAB Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cell Impact and VIMAB Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cell Impact AB and VIMAB Group AB, you can compare the effects of market volatilities on Cell Impact and VIMAB Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cell Impact with a short position of VIMAB Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cell Impact and VIMAB Group.

Diversification Opportunities for Cell Impact and VIMAB Group

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Cell and VIMAB is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Cell Impact AB and VIMAB Group AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VIMAB Group AB and Cell Impact is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cell Impact AB are associated (or correlated) with VIMAB Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VIMAB Group AB has no effect on the direction of Cell Impact i.e., Cell Impact and VIMAB Group go up and down completely randomly.

Pair Corralation between Cell Impact and VIMAB Group

Assuming the 90 days horizon Cell Impact AB is expected to under-perform the VIMAB Group. In addition to that, Cell Impact is 1.65 times more volatile than VIMAB Group AB. It trades about -0.03 of its total potential returns per unit of risk. VIMAB Group AB is currently generating about 0.02 per unit of volatility. If you would invest  840.00  in VIMAB Group AB on August 27, 2024 and sell it today you would lose (90.00) from holding VIMAB Group AB or give up 10.71% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cell Impact AB  vs.  VIMAB Group AB

 Performance 
       Timeline  
Cell Impact AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cell Impact AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
VIMAB Group AB 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in VIMAB Group AB are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, VIMAB Group unveiled solid returns over the last few months and may actually be approaching a breakup point.

Cell Impact and VIMAB Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cell Impact and VIMAB Group

The main advantage of trading using opposite Cell Impact and VIMAB Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cell Impact position performs unexpectedly, VIMAB Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VIMAB Group will offset losses from the drop in VIMAB Group's long position.
The idea behind Cell Impact AB and VIMAB Group AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device